Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Gains from Sales and Divestitures (2020 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Gains from Sales and Divestitures data on record, last reported at $910939.0 in Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures changed N/A to $910939.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $910939.0, a N/A change, with the full-year FY2025 number at $910939.0, changed N/A from a year prior.
  • Gains from Sales and Divestitures reached $910939.0 in Q4 2025 per NBP's latest filing, up from $80044.4 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for NBP hit a ceiling of $910939.0 in Q4 2025 and a floor of $80044.4 in Q4 2023.
  • A 4-year average of $302894.7 and a median of $110297.8 in 2021 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 39.92% in 2021, then fell 20.96% in 2023.
  • Tracing NBP's Gains from Sales and Divestitures over 4 years: stood at $119328.0 in 2021, then dropped by 15.14% to $101267.6 in 2022, then dropped by 20.96% to $80044.4 in 2023, then soared by 1038.04% to $910939.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for NBP at $910939.0 in Q4 2025, $80044.4 in Q4 2023, and $101267.6 in Q4 2022.